Abstract:Mutations in the solute linked carrier family 4 member 11 ( SLC4A11) gene are associated with congenital hereditary endothelial dystrophy (CHED) and Fuchs corneal endothelial dystrophy type 4 (FECD4), both characterized by corneal endothelial cell (CEnC) dysfunction and/or cell loss leading to corneal edema and visual impairment. In this study, we characterize the impact of CHED-/FECD4-associated SLC4A11 mutations on CEnC function and SLC4A11 protein localization by generating and comparing human CEnC (hCEnC) lines expressing wild type SLC4A11 (SLC4A11 WT ) or mutant SLC4A11 harboring CHED-/FECD4-associated SLC4A11 mutations (SLC4A11 MU ). SLC4A11 WT and SLC4A11 MU hCEnC lines were generated to express either SLC4A11 variant 2 (V2 WT and V2 MU ) or variant 3 (V3 WT and V3 MU ), the two major variants expressed in ex vivo hCEnC. Functional assays were performed to assess cell barrier, proliferation, viability, migration, and NH 3 -induced membrane conductance. We demonstrate SLC4A11 -/- and SLC4A11 MU hCEnC lines exhibited increased migration rates, altered proliferation and decreased cell viability compared to SLC4A11 WT hCEnC. Additionally, SLC4A11 -/- hCEnC demonstrated decreased cell-substrate adhesion and membrane capacitances compared to SLC4A11 WT hCEnC. Induction with 10mM NH 4 Cl led SLC4A11 WT hCEnC to depolarize; conversely, SLC4A11 -/- hCEnC hyperpolarized and the majority of SLC4A11 MU hCEnC either hyperpolarized or had minimal membrane potential changes following NH 4 Cl induction. Immunostaining of primary hCEnC and SLC4A11 WT hCEnC lines for SLC4A11 demonstrated predominately plasma membrane staining with poor or partial colocalization with mitochondrial marker COX4 within a subset of punctate subcellular structures. Overall, our findings suggest CHED-associated SLC4A11 mutations likely lead to hCEnC dysfunction, and ultimately CHED, by interfering with cell migration, proliferation, viability, membrane conductance, barrier function, and/or cell surface localization of the SLC4A11 protein in hCEnC. Additionally, based on their similar subcellular localization and exhibiting similar cell functional profiles, protein isoforms encoded by SLC4A11 variant 2 and variant 3 likely have highly overlapping functional roles in hCEnC.

Advances in etiologies and management of congenital hereditary endothelial dystrophy

Whole Exome Sequencing Identified FAM149A As a Plausible Causative Gene for Congenital Hereditary Endothelial Dystrophy, Affecting Nrf2-Antioxidant Signaling Upon Oxidative Stress

[Identification of novel mutations of SLC4A11 gene in patients with congenital hereditary endothelial dystrophy].

Compound Heterozygous Mutations in the SLC4A11 Gene Associated with Congenital Hereditary Endothelial Dystrophy in a Chinese Family

Contribution of VEGF and PEDF to Choroidal Angiogenesis: A Need for Balanced Expressions

Progress in the study of molecular genetics of BIGH3 related corneal dystrophy

Evolution of therapeutic strategy based on oxidant-antioxidant balance for fuchs endothelial corneal dystrophy

The Role of Corneal Endothelium in Macular Corneal Dystrophy Development and Recurrence

Energy Shortage in Human and Mouse Models of SLC4A11-Associated Corneal Endothelial Dystrophies

Investigation of the functional impact of CHED- and FECD4-associated SLC4A11 mutations in human corneal endothelial cells

Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs' endothelial corneal dystrophy

Advances in the Diagnosis and Treatment for Ocular Complication on Mucopolysaccharidosis

Advances in the treatment of macular corneal dystrophy

Advances in Culture, Expansion and Mechanistic Studies of Corneal Endothelial Cells: a Systematic Review

Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies

Clinical management strategies for familial exudative vitreoretinopathy

A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy.

Descemet Stripping Endothelial Keratoplasty in Pediatric Patients with Congenital Hereditary Endothelial Dystrophy

Gene-based therapeutic tools in the treatment of Cornea Disease.

Clinical consequences of herpes simplex virus DNA in donor corneas: Different prognosis and management of endothelial keratoplasty and deep anterior lamellar keratoplasty

Long-Term Observation and Sequencing Analysis of SKPs-Derived Corneal Endothelial Cell-Like Cells for Treating Corneal Endothelial Dysfunction